Treatment patterns of multiple sclerosis patients treated with disease-modifying therapies in Puerto Rico

被引：0
|
作者：
Chia, J. [1 ]
Nunez, M. [1 ]
Hernandez, H. [2 ]
Jimenez, G. [2 ]
Ong, A. [1 ]
Hashemi, L. [1 ]
机构：
[1] Sanofi, Cambridge, MA USA
[2] Special Care Pharm Serv, San Juan, PR USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
v
引用
收藏
页码：764 / 764
页数：1
相关论文
共 50 条
  • [31] Effects of disease-modifying therapies on lipid parameters in patients with multiple sclerosis
    Koca, Nizameddin
    Seferoglu, Meral
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 77
  • [32] The influence of disease-modifying therapies on gut microbiota in patients with multiple sclerosis
    Flaskamp, Martina
    Andlauer, Till
    Uibel, Paula
    Held, Friederike
    Jud, Sarah
    Troci, Alba
    Afzali, Ali
    Gasperi, Christiane
    Giglhuber, Katrin
    Strauss, Eva-Maria
    Berthele, Achim
    Bang, Corinna
    Franke, Andre
    Hemmer, Bernhard
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 328 - 328
  • [33] Adherence to disease-modifying therapies and attitudes regarding disease in patients with multiple sclerosis
    Ozura, Ana
    Kovac, Lea
    Sega, Sasa
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S6 - S11
  • [34] Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
    Lee, Chi-Yan
    Chan, Koon-Ho
    PHARMACEUTICS, 2024, 16 (01)
  • [35] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Daniel M. Hartung
    Current Neurology and Neuroscience Reports, 2021, 21
  • [36] Disease-modifying therapies in Chinese children with multiple sclerosis
    Yang, Fen
    Huang, De-hui
    Yang, Yang
    Wu, Wei-ping
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (05) : 482 - 486
  • [37] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Hartung, Daniel M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (07)
  • [38] Switching disease-modifying therapies in multiple sclerosis patients: A study on 110 patients
    Morra, V. Brescia
    Coppola, G.
    Vacca, G.
    Longobardi, M.
    Ascione, S.
    Schiavone, V.
    Pagano, A.
    Bonavita, V.
    Orefice, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 263 - 264
  • [39] Comparing the efficacy of disease-modifying therapies in multiple sclerosis
    Mitsikostas, Dimos D.
    Goodin, Douglas S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 18 : 109 - 116
  • [40] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Kretzschmar, Benedikt
    Pellkofer, Hannah
    Weber, Martin S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04)
12345